Hirsch 1997.
| Methods | Randomised DBPC trial | |
| Participants | Children 15 active (10 m) 15 placebo (10 m) |
|
| Interventions | 12 months SLIT cumulative dose 570 mcg Derp 1 | |
| Outcomes | Diary scores SPT | |
| Notes | Jadad scale 5/5 | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Adequate sequence generation? | Low risk | Subjects were randomised according to a code provided by the manufacturer |
| Allocation concealment? | Low risk | Central allocation |
| Blinding? All outcomes | Low risk | Investigators and participants were blinded to treatment assignment for the duration of the study |
| Incomplete outcome data addressed? All outcomes | Low risk | Participants lost to follow‐up or excluded were accounted for along with patients followed to designated follow‐up periods |
| Free of selective reporting? | Low risk | The specified outcomes in the methodology were reported in the results section |
| Free of other bias? | Unclear risk | Insufficient information to assess whether an important risk of bias exists |